Literature DB >> 18616663

Assessment of alcohol use among methadone maintenance patients by direct ethanol metabolites and self-reports.

Friedrich Martin Wurst1, Kenneth M Dürsteler-MacFarland, Volker Auwaerter, Sonja Ergovic, Natasha Thon, Michel Yegles, Claudia Halter, Wolfgang Weinmann, Gerhard A Wiesbeck.   

Abstract

BACKGROUND: Heavy alcohol consumption may accelerate the progression of hepatitis C (HCV)-related liver disease and/or limit efforts at antiviral treatment. As most of the patients in methadone maintenance treatment (MMT) suffer from hepatitis C infection, this study was conducted to identify the alcohol intake among these patients at a Swiss Psychiatric University Clinic by self-reports and direct ethanol metabolites as biomarkers of ethanol consumption. PATIENTS AND METHODS: A convenience sample of 40 MMT patients (15 women, 25 men; median age 39 years) of the total 124 patients was asked and consented to participate in this study. This sample was not different in age, gender distribution, and rate of hepatitis C infection from the total sample. The Alcohol Use Disorders Identification Test (AUDIT) and self-reported ethanol intake during the previous 7 days were assessed. In addition, ethyl glucuronide (EtG) in urine, and fatty acid ethyl esters (FAEEs) and EtG in hair were determined using LC-MS/MS and gas chromatograph/mass spectrometer. The limit of quantitation for UEtG, HEtG, and FAEEs were 0.1 mg/l, 2.3 pg/mg, and 0.1 ng/mg, respectively.
RESULTS: Fourteen participants reported abstinence from alcohol for the previous 7 days. AUDIT scores were > or =8 in 15 male and >5 in 5 female participants. Direct ethanol metabolites were as follows (median, min, max, standard deviation): UEtG (19 positives; 9.91, 1.38 to 251, 62.39 mg/l); the values of HEtG were 17.65, 0 to 513, 105.62 pg/mg [in 2 cases no material, 8 abstinent (up to 7 pg/mg), 15 social drinkers (up to 50 g per day), and 15 excessive users (>50/60 g/d)]. For the 13 cases, where enough material for additional determination of HFAEEs was available, the values were 0.32, 0 to 1.32, 0.44 ng/mg. Among the 30 HEtG-positive participants, 20 had not reported the corresponding ethanol intake using question 1 (frequency) and 2 (quantity) of the AUDIT. Of the 14 participants reporting no alcohol intake during the previous 7 days, 4 were UEtG-positive. HEtG and AUDIT correlated significantly (r = 0.622, p < 0.0001), but this was not the case for UEtG and self-reported ethanol intake during the previous 7 days.
CONCLUSION: (1) HEtG identified 20 cases of daily ethanol intake of more than 20 g, that would have been missed by the sole use of question 1 (frequency) and 2 (quantity) of the AUDIT. (2) Using the total score of the AUDIT, HEtG confirmed 10 more cases positive for alcohol intake. (3) Episodic heavy drinking is with 22.5% more frequent than in general population, and (4) of the 14 participants who reported no alcohol intake during the previous 7 days, 4 were UEtG positive. Improved detection of alcohol consumption, which is hazardous or harmful in the context of HCV and opiate dependence, would allow for earlier intervention in this population which is at particular risk of liver disease and fatal respiratory-depressed overdose. The combined use of self-reports and direct ethanol metabolites seems promising.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18616663     DOI: 10.1111/j.1530-0277.2008.00724.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  10 in total

1.  Single-session motivational intervention to decrease alcohol use during pregnancy.

Authors:  Robin L Osterman; Adam C Carle; Robert T Ammerman; Donna Gates
Journal:  J Subst Abuse Treat       Date:  2014-02-10

2.  Comparison of opiate-primary treatment seekers with and without alcohol use disorder.

Authors:  Bryan Hartzler; Dennis M Donovan; Zhen Huang
Journal:  J Subst Abuse Treat       Date:  2010-07-03

3.  Determining ethyl glucuronide cutoffs when detecting self-reported alcohol use in addiction treatment patients.

Authors:  Jessica M Lowe; Michael G McDonell; Emily Leickly; Frank A Angelo; Roger Vilardaga; Sterling McPherson; Debra Srebnik; John Roll; Richard K Ries
Journal:  Alcohol Clin Exp Res       Date:  2015-04-10       Impact factor: 3.455

4.  Biographical data of patients in drug substitution programmes.

Authors:  Hans Tönies
Journal:  Wien Med Wochenschr       Date:  2012-01

Review 5.  [What ethanol metabolites as biological markers tell us about alcohol use].

Authors:  Friedrich Martin Wurst; Natasha Thon; Wolfgang Weinmann; Michel Yegles; Ulrich Preuss
Journal:  Wien Med Wochenschr       Date:  2013-12-10

6.  Ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials.

Authors:  Peter I Jatlow; Ann Agro; Ran Wu; Haleh Nadim; Benjamin A Toll; Elizabeth Ralevski; Christine Nogueira; Julia Shi; James D Dziura; Ismene L Petrakis; Stephanie S O'Malley
Journal:  Alcohol Clin Exp Res       Date:  2014-04-28       Impact factor: 3.455

7.  The validity of phosphatidylethanol in dried blood spots of newborns for the identification of prenatal alcohol exposure.

Authors:  Ludmila N Bakhireva; Lawrence Leeman; Renate D Savich; Sandra Cano; Hilda Gutierrez; Daniel D Savage; William F Rayburn
Journal:  Alcohol Clin Exp Res       Date:  2014-02-11       Impact factor: 3.455

8.  The Impact of Enrolment in Methadone Maintenance Therapy on Initiation of Heavy Drinking among People Who Use Heroin.

Authors:  Jan Klimas; Evan Wood; Paul Nguyen; Huiru Dong; Michael John Milloy; Thomas Kerr; Kanna Hayashi
Journal:  Eur Addict Res       Date:  2016-04-06       Impact factor: 3.015

9.  Evaluation of alcohol use pattern among OST patients using alcohol biomarkers: Report from community clinics in India.

Authors:  Rizwana Quraishi; Mohit Varshney; Ravindra V Rao; Atul Ambekar
Journal:  Indian J Psychiatry       Date:  2022-06-08       Impact factor: 2.983

Review 10.  Focus on: biomarkers of fetal alcohol exposure and fetal alcohol effects.

Authors:  Ludmila N Bakhireva; Daniel D Savage
Journal:  Alcohol Res Health       Date:  2011
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.